Dr Lang Tran

Director of Quantitiative Toxicology

Institute of Occupational Medicine (IOM)

Research Avenue North
Riccarton
Edinburgh
EH14 4AP
United Kingdom
PH: +44 (0) 1314498050
Email: [email protected]

Background

Dr C Lang Tran is Director of Quantitiative Toxicology at the Institute of Occupational Medicine (IOM). With over 16 years experience in the fields of toxicology and ecotoxicology, he has contributed over 50 peer reviews.

A researcher at the forefront of particle toxicology, he has been heavily involved in the evolution of Nanoparticle Toxicology as a research field. He currently leads EU FP7 project ENPRA and EU FP6 project PARTICLE_RISK, both of which are investigating the toxicological properties of nanoparticles, and is also involved with FP7 projects NanoTEST, Nanommune and NanoImpactNet. He is a founding member of SnIRC, the Safety of Nanomaterials Interdisciplinary Research Centre.

Dr Tran has been involved in the writing of several major Government reviews of nanotechnology, including reports from DEFRA and HSE. He is involved in collaborative work into nanotoxicology QSAR Modelling with the JRC, and with NIOSH on Nanotechnology Risk Assessment, and was co-author of the HARN and CELL PEN reports, examining risks of high aspect nanomaterials (HARN), and penetration & translocation of NPs through cells within the body (CELL PEN).

Ask A Question

Do you have a question you'd like to ask this Expert?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.